FDA approves new $1,000-a-day hepatitis C pills

The Food and Drug Administration has approved a new drug that promises to treat hepatitis C with a daily pill instead of the more common weekly injection. The drug, called Sovaldi from Gilead Sciences, has been designed to block the protein hepatitis C uses to replicate itself. Hepatitis C has multiple strains, and can require different methods of attack. Today's approval is the latest of such drug treatments;

via Tech News Headlines - Yahoo! News http://www.theverge.com/2013/12/6/5184168/fda-approves-new-1000-a-day-hepatitis-c-pills